Anthony Cao
0009-0009-4062-3767
Publication & Citation Trends
Most Cited Works
Publications
82 total
Brentuximab Vedotin–Driven Microtubule Disruption Results in Endoplasmic Reticulum Stress Leading to Immunogenic Cell Death and Antitumor Immunity PDF
Cited by 49
OpenAlex
CD47-blocking Antibody ZL-1201 Promotes Tumor-associated Macrophage Phagocytic Activity and Enhances the Efficacy of the Therapeutic Antibodies and Chemotherapy OA
Cited by 11
Semantic Scholar
809 Anti-CLDN18.2 antibody ZL-1211 enhances anti-tumor activities in combination with chemotherapy in gastric cancer models OA
Cited by 1
Semantic Scholar
Correction: RORγt Represses IL-10 Production in Th17 Cells To Maintain Their Pathogenicity in Inducing Intestinal Inflammation OA
Cited by 3
Semantic Scholar
618 Vedotin ADCs induce ER stress and elicit hallmarks of ICD across multiple cancer indications OA
Cited by 7
Semantic Scholar
Abstract 5581: Enfortumab vedotin, an anti-Nectin-4 ADC demonstrates bystander cell killing and immunogenic cell death anti-tumor activity mechanisms of action in urothelial cancers
Cited by 25
Semantic Scholar
Abstract 221: Tisotumab vedotin induces anti-tumor activity through MMAE-mediated, Fc-mediated, and Fab-mediated effector functionsin vitro
Cited by 14
Semantic Scholar
Neutrophils Promote Amphiregulin Production in Intestinal Epithelial Cells through TGF-β and Contribute to Intestinal Homeostasis PDF
Cited by 69
OpenAlex
Research Topics
Phagocytosis and Immune Regulation
(29)
Immune cells in cancer
(21)
Monoclonal and Polyclonal Antibodies Research
(19)
Immunotherapy and Immune Responses
(14)
Immune Cell Function and Interaction
(12)
Frequent Co-Authors
Affiliations
Exelixis (United States)
Texas A&M University at Galveston
Liverpool Hospital
Bristol-Myers Squibb (United States)
Menlo School